| Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity PW Burridge, YF Li, E Matsa, H Wu, SG Ong, A Sharma, A Holmström, ... Nature medicine 22 (5), 547-556, 2016 | 692 | 2016 |
| High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells WJC Sharma A, Burridge PW, McKeithan WL, Serrano R, Shukla P, Sayed N ... Sci Transl Med. 9 (377), 2017 | 352 | 2017 |
| Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells PW Burridge, A Holmström, JC Wu Current protocols in human genetics 87 (1), 21.3. 1-21.3. 15, 2015 | 213 | 2015 |
| Comparison of non-human primate versus human induced pluripotent stem cell-derived cardiomyocytes for treatment of myocardial infarction X Zhao, H Chen, D Xiao, H Yang, I Itzhaki, X Qin, T Chour, A Aguirre, ... Stem cell reports 10 (2), 422-435, 2018 | 60 | 2018 |
| Red blood cell distribution width and its relation to cardiac function and biomarkers in a prospective hospital cohort referred for echocardiography A Holmström, R Sigurjonsdottir, O Hammarsten, D Gustafsson, M Petzold, ... European journal of internal medicine 23 (7), 604-609, 2012 | 31 | 2012 |
| Frequent mild cognitive deficits in several functional domains in elderly patients with heart failure without known cognitive disorders A Nordlund, J Berggren, A Holmström, M Fu, A Wallin Journal of Cardiac Failure 21 (9), 702-707, 2015 | 29 | 2015 |
| Increased comorbidities in heart failure patients≥ 85 years but declined from> 90 years: data from the Swedish Heart Failure Registry A Holmström, R Sigurjonsdottir, M Edner, Å Jonsson, U Dahlström, ... International journal of cardiology 167 (6), 2747-2752, 2013 | 22 | 2013 |
| High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Sci Transl Med 9 A Sharma, PW Burridge, WL McKeithan, R Serrano, P Shukla, N Sayed, ... | 19 | 2017 |
| Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs. 3D engineered heart tissue H Yang, N Shao, A Holmström, X Zhao, T Chour, H Chen, I Itzhaki, H Wu, ... Cardiovascular research 117 (9), 2125-2136, 2021 | 17 | 2021 |
| Heart dysfunction in patients with acute ischemic stroke or TIA does not predict all-cause mortality at long-term follow-up A Holmström, MLX Fu, C Hjalmarsson, L Bokemark, B Andersson BMC neurology 13, 1-8, 2013 | 16 | 2013 |
| An integrated multiple marker modality is superior to NT-proBNP alone in prognostic prediction in all-cause mortality in a prospective cohort of elderly heart failure patients A Holmström, R Sigurjonsdottir, O Hammarsten, M Petzold, D Gustafsson, ... European Geriatric Medicine 4 (6), 365-371, 2013 | 9 | 2013 |
| Assessment of a multi-marker risk score for predicting cause-specific mortality at three years in older patients with heart failure and reduced ejection fraction C Bjurman, A Holmström, M Petzold, O Hammarsten, ML Fu Cardiology Journal 22 (1), 31-36, 2015 | 8 | 2015 |
| Re-evaluation of prognostic significance of NT-proBNP in a 5-year follow-up study assessing all-cause mortality in elderly patients (≥ 75 years) admitted to hospital due to … A Holmström, M Petzold, MLX Fu European Geriatric Medicine 4 (1), 8-14, 2013 | 4 | 2013 |
| Levels of copeptin among elderly patients in relation to systolic heart failure and heart failure with normal ejection fraction A Holmström, R Sigurjonsdottir, MLX Fu, D Gustafsson, M Petzold, ... European Geriatric Medicine 4 (3), 139-144, 2013 | 2 | 2013 |
| The Clinical Relevance and Potential Mechanism of Biomarkers in Elderly Heart Failure Patients A Holmström | | 2013 |
| The Clinical Relevance and Potential Mechanism of Biomarkers in Elderly Heart A Holmström | | 2013 |
